Trial · NCT04015557
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in aspartate transaminase (AST) in 4 hours | 4 hours | A difference \>30% between pre and pos Acetaminophen administration will be considered clinically significant. |
| Primary | Change in aspartate transaminase (AST) in 6 hours | 6 hours | A difference \>30% between pre and pos Acetaminophen administration will be considered clinically significant. |
| Primary | Change in alanine transaminase (ALT) in 4 hours | 4 hours | A difference \>30% between pre and pos Acetaminophen administration will be considered clinically significant. |
| Primary | Change in alanine transaminase (ALT) in 6 hours | 6 hours | A difference \>30% between pre and pos Acetaminophen administration will be considered clinically significant. |
| Secondary | Change in sulfhydryl levels in 2 hours | 2 hours | A difference \>30% between pre and pos measurements will be considered clinically significant. |
| Secondary | Change in sulfhydryl levels in 4 hours | 4 hours | A difference \>30% between pre and pos measurements will be considered clinically significant. |
| Secondary | Change in sulfhydryl levels in 6 hours | 6 hours | A difference \>30% between pre and pos measurements will be considered clinically significant. |
| Secondary | Change in sulfhydryl levels in 8 hours | 8 hours | A difference \>30% between pre and pos measurements will be considered clinically significant. |
| Secondary | Change in plasma GST activity in 2 hours | 2 hours | A difference \>30% between pre and pos measurements will be considered clinically significant. |
| Secondary | Change in plasma GST activity in 4 hours | 4 hours | A difference \>30% between pre and pos measurements will be considered clinically significant. |
| Secondary | Change in plasma GST activity in 6 hours | 6 hours | A difference \>30% between pre and pos measurements will be considered clinically significant. |
| Secondary | Change in plasma GST activity in 8 hours | 8 hours | A difference \>30% between pre and pos measurements will be considered clinically significant. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04015557/registered